Dr. Anita Rogowicz-Frontczak | Medicine | Research Excellence Award

Assistant Professor | Poznan University of Medical Science | Poland

Dr. Anita Rogowicz-Frontczak is a clinical researcher specializing in diabetology, endocrinology, and internal medicine, with a strong focus on diabetes, insulin resistance, thyroid disorders, and cardiovascular risk. Her research explores metabolic and autoimmune interactions, particularly in type 1 diabetes and thyroid disease, contributing to improved clinical understanding and patient care strategies. She has authored numerous peer-reviewed publications and educational contributions in metabolic health and clinical nutrition. Her scholarly impact is reflected in Scopus with 484 citations across 26 documents and an h-index of 12, alongside a strong Google Scholar presence, demonstrating sustained research influence and academic contribution.

Citation Metrics (Scopus)

500

400

300

200

100

Citations
484

Documents
26

h-index
12

■ Citations
■ Documents
■ h-index

View Scopus Profile View ORCID Profile

Featured Publications

Does Resistant Starch Formed by Cooling Pasta Decrease the Postprandial Glycemic Response in Type 1 Diabetes? A Randomized Single-Blind Crossover Study

– Nutrients, 2026

Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes

– Acta Diabetologica, 2018

Higher free triiodothyronine concentration is associated with lower prevalence of microangiopathic complications and better metabolic control in adult euthyroid people with type 1 diabetes

– Endocrine, 2018

Insulin resistance in endocrine disorders-treatment options

– Scandinavian Journal, 2018

Zinc transporter 8 autoantibodies (ZnT8-ab) are associated with higher prevalence of multiple diabetes-related autoantibodies in adults with type 1 diabetes

– Diabetes Research, 2018

Dr. Friba Nurmukhamma | Medicine | Best Researcher Award

Khoja Akhmet Yassawi International Kazakh-Turkish University | Kazakhstan

Dr. Friba NurmukhammadNasrullakyzy is a cardiologist, senior researcher, and PhD scholar specializing in cardiovascular pathology, with a particular focus on coronary artery disease (CAD), stenting, and post-coronary artery bypass grafting (CABG) outcomes. Her research explores the mechanisms of high residual platelet reactivity (HRPR) and dyslipidemia, contributing to improved treatment algorithms and predictive models aimed at reducing mortality in patients with complex cardiovascular conditions. Dr. Friba’s innovative work integrates clinical insights with advanced diagnostic methodologies and personalized therapeutic approaches, emphasizing non-statin therapies, platelet reactivity modulation, and functional diagnostics in cardiology. She has authored multiple peer-reviewed publications indexed in Scopus and other scientific databases, reflecting a growing international research presence. Her Scopus h-index is 3, and her research impact is further supported by citations across both Scopus and Google Scholar databases. Dr. Friba’s current projects involve developing mortality prediction scales and individualized treatment algorithms for patients with HRPR, aiming to advance precision medicine in cardiology. Her scientific contributions underscore her commitment to translational cardiovascular research and her role in fostering evidence-based practices within clinical cardiology.

Featured Publications

Mussagaliyeva, A., Zhangelova, S., Danyarova, L., Nurmukhammad, F., Kapsultanova, D., Sakhov, O., Rustamova, F., Sugraliyev, A., & Akhmentayeva, D. (2025). Residual platelet reactivity and dyslipidemia in post-CABG patients undergoing repeat revascularization: Insights from Kazakhstan. Diseases, 13(11), 365.

Nurmukhammad, F. N., Zhangelova, S. B., & Kapsultanova, D. A. (2025). Non-statin therapy in patients with elevated LDL-C and high platelet reactivity: A narrative review. Medical Journal of Malaysia, 80(2), 258–265.

Zhangelova, S. B., Nurmukhammad, F. N., & Nurdinov, N. (2023). High residual platelet reactivity as a predictor of atherothrombosis in patients with coronary heart disease. Science and Healthcare, 25(3), 25–31.

Mussagaliyeva, A., Zhangelova, S., Nurmukhammad, F., & Kapsultanova, D. (2025). Residual platelet reactivity and dyslipidemia in post-CABG patients: Preprint insights from Kazakhstan. Preprints, 2025(09), 2498.